- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
More ▼
Key statistics
On Wednesday, Edwards Lifesciences Corp (EW:NYQ) closed at 90.21, -6.15% below its 52-week high of 96.12, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 90.95 |
---|---|
High | 91.94 |
Low | 90.03 |
Bid | 89.60 |
Offer | 90.49 |
Previous close | 90.34 |
Average volume | 2.37m |
---|---|
Shares outstanding | 602.60m |
Free float | 597.18m |
P/E (TTM) | 38.83 |
Market cap | 54.44bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of May 23 2024 00:00 BST.
More ▼